takeaways:
Macquarie analysts: "..It particularly singled out spodumene – a popular source of lithium, given its lower production costs & certainty of supply – as a big beneficiary.
..Analysts upgraded their spodumene price forecasts by" 7% 2021, 30% 2022, 17% for 2023
do they have AVZ in their portfolio?